Prevounce Health has introduced Pylo OX1-LTE, a new blood oxygen device designed for remote patient monitoring (RPM) programmes.

The pulse oximeter is clinically validated and offers advantages for patients with chronic respiratory conditions and other health scenarios requiring consistent monitoring.

The OX1-LTE’s cellular connectivity allows it to roam on multiple networks, ensuring reliable data transmission even in areas with weak signals.

This feature is particularly beneficial for chronic respiratory patients and those needing heart rate monitoring, including Covid-19 patients. The device is also cost-effective, which supports the expansion of RPM programmes.

Federal Communications Commission (FCC) certified and the Food and Drug Administration (FDA) 510(k) cleared, the Pylo OX1-LTE can provide blood oxygen saturation and pulse rate readings with high accuracy.

It features an OLED screen and an ergonomic design for ease of use. Designed to be durable and ready to use straight out of the box, the device requires no configuration, reducing the potential for device failure.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Available for integration with the Prevounce remote care management platform, the OX1-LTE also works with third-party health software through the Pylo cloud API.

Healthcare organisations can customise the device and packaging for a branded patient experience, with Prevounce offering additional services such as inventory management, logistics, and device refurbishment.

Prevounce founder and CEO Daniel Tashnek said: “We’re excited to add OX1-LTE to the family of Pylo devices available for use in RPM programmes.

“The OX1-LTE couldn’t be simpler for patients to use, which will boost RPM programme engagement and participation while reducing the clinician and technical support work required to scale remote monitoring programmes.”

Prevounce Health’s Pylo OX1-LTE is now available across the US.

In June 2024, Prevounce launched Pylo GL1-LTE, a cellular-connected remote blood glucose meter for remote monitoring of patients.

The device is designed to enhance RPM programmes for diabetes management by ensuring reliable data transmission across the US.